Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
China Traditional Chinese Medicine (570 HK)
Watchlist
240
Analysis
Health Care
•
Hong Kong
China Traditional Chinese Medicine Co. Limited, through its subsidiaries, manufactures and sells medicine and pharmaceutical products in China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
China Resources Sanjiu Medical & Pharma
•
20 Aug 2023 09:37
China Healthcare Weekly (Aug.18) - TCM Formula Granules VBP, Global Financing Rebound, CR Sanjiu
China's first TCM formula granules VBP begins.Primary market financing in global biopharma industry rebound, but IPO remains weak.China Resources...
Xinyao (Criss) Wang
Follow
379 Views
Share
bullish
•
China Traditional Chinese Medicine
•
02 Aug 2023 08:55
China Traditional Chinese Medicine (570.HK) 23H1-Positive Profit Alert Reinforce Optimism About 2023
The Positive Profit Alert released by China TCM confirms our optimism, which makes us look forward to the 2023 full year results. The positive...
Xinyao (Criss) Wang
Follow
265 Views
Share
bullish
•
Thematic (Sector/Industry)
•
13 Jun 2023 08:55
The Cyclicality of China Healthcare - Policy Environment, the Industry, and Investment Opportunities
Without industry beta, China healthcare companies still have opportunity to achieve countercyclical breakthrough.Investors need to be in line with...
Xinyao (Criss) Wang
Follow
316 Views
Share
bullish
•
China Traditional Chinese Medicine
•
12 Apr 2023 08:55
China Traditional Chinese Medicine (570.HK) - Looking Forward to a Performance Turnaround in 2023
As TCM granules business would rebound significantly, China TCM would achieve performance turnaround in 2023. As the industry leader, China TCM...
Xinyao (Criss) Wang
Follow
349 Views
Share
bullish
•
Thematic (Sector/Industry)
•
30 Mar 2023 08:55
China Traditional Chinese Medicine (TCM) Industry - TCM Is Becoming Indispensable in the Portfolio
The current policy environment in China indicates that TCM is core asset of pharmaceuticals, not innovative drug R&D. It''s time to take TCM...
Xinyao (Criss) Wang
Follow
329 Views
Share
First
Previous
37
38
39
40
41
42
43
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3
x